Columbia Contrarian Core Fund Class I3 logo

Columbia Contrarian Core Fund Class I3 (COFYX)

Market Open
12 Jun, 12:10
NASDAQ NASDAQ
$
42. 73
+0.75
+1.7866%
$
18.48B Market Cap
0.87% Div Yield
0 Volume
$ 41.98
Previous Close
Investors:
Add Transaction
Day Range
42.73 42.73
Year Range
36.64 44.16
Want to track COFYX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

COFYX trading today higher at $42.73, an increase of 1.7866% from yesterday's close, completing a monthly decrease of -3.1944% or -$1.41. Over the past 12 months, COFYX stock gained 6.7183%.
COFYX pays dividends to its shareholders, with the most recent payment made on Dec 11, 2023. The next estimated payment will be in 11 Dec 2024 on Dec 11, 2024 for a total of $1.00314.
The stock of the company had never split.
The company's stock is traded on one exchange.

COFYX Chart

People also search for

American Funds Investment Company of America Class R-1
$ 66.4
+1.8561%
American Funds Fundamental Investors® Class F-2
$ 102.64
+2.3126%
American Funds Investment Company of America® Class R-2
$ 66.52
+1.8527%
Fidelity Contrafund
$ 25.87
+1.8103%
American Funds New Perspective Fund Class A
$ 73.84
+2.5983%

Columbia Contrarian Core Fund Class I3 Investors

Name Quantity Cost Value Profit ($) Gain (%)
CGL
Chester Gary Lloyd Coston, McIsaac & Partners
1,158 $35,236.82 $48,612.84 $13,376.02 37.96%

Columbia Contrarian Core Fund Class I3 (COFYX) FAQ

What is the stock price today?

The current price is $42.73.

On which exchange is it traded?

Columbia Contrarian Core Fund Class I3 is listed on NASDAQ.

What is its stock symbol?

The ticker symbol is COFYX.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.87%.

What is its market cap?

As of today, the market cap is 18.48B.

Has Columbia Contrarian Core Fund Class I3 ever had a stock split?

No, there has never been a stock split.

Columbia Contrarian Core Fund Class I3 Profile

NASDAQ Exchange
US Country

Overview

The investment strategy focuses on achieving total return, which encompasses both long-term capital appreciation and current income. Primarily, the fund is invested in common stocks, following a stringent criterion that requires at least 80% of its net assets to be allocated towards equity securities. These securities are of U.S. companies that not only have large market capitalizations, typically exceeding $2 billion, but are also judged by the fund's investment manager to be undervalued. Additionally, these companies are expected to offer the potential for long-term growth coupled with current income, making them attractive investment opportunities. By adhering to these principles, the fund aims to strategically position itself in the market, focusing on companies that are believed to provide the best prospects for return on investment.

Products and Services

The investment portfolio offers a focused range of products and services designed to meet the investment objectives of capital appreciation and current income:

  • Common Stocks Investment: The core of the investment strategy is the allocation of at least 80% of the fund's net assets in common stocks. This exploitation of equity securities forms the backbone of the pursuit for long-term capital growth.
  • Large Market Capitalization Equities: A significant emphasis is placed on investing in U.S. companies with large market capitalizations, typically above $2 billion. These companies are carefully selected based on their perceived undervaluation and potential for long-term growth and current income, underpinning the fund's strategy for achieving total return.
  • Foreign Securities Investment: To diversify the investment portfolio and possibly enhance returns, up to 20% of the fund's net assets may be invested in foreign securities. This allows for a broader exploration of global markets and opportunities outside the U.S. that may contribute to the fund's income and growth objectives.

Contact Information

Address: Columbia Funds Series Trust I
Phone: 800-345-6611